Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

BACKGROUND: Papillary renal cell carcinoma (pRCC) is the 2nd most frequent histological type of kidney cancer and accounts for approximately 15% of all renal cell carcinoma. It has a poorer prognosis than clear cell RCC (ccRCC) with a lack of standard treatments. CASE PRESENTATION: We report the cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochigneux, Philippe, Thomassin-Piana, Jeanne, Laibe, Sophy, Brunelle, Serge, Salem, Naji, Escudier, Bernard, Vassal, Gilles, Gravis, Gwenaelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251103/
https://www.ncbi.nlm.nih.gov/pubmed/30466410
http://dx.doi.org/10.1186/s12885-018-5049-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251103/
https://www.ncbi.nlm.nih.gov/pubmed/30466410
http://dx.doi.org/10.1186/s12885-018-5049-3

Ejemplares similares